The major role of junctional diversity in the horse antibody repertoire. 2022

Carlena Navas, and Taciana Manso, and Fabio Martins, and Lucas Minto, and Rennan Moreira, and João Minozzo, and Bruno Antunes, and André Vale, and Jonathan R McDaniel, and Gregory C Ippolito, and Liza F Felicori
Laboratory of Synthetic Biology and Biomimetics, Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas - ICB, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil; University of Carabobo, Faculty of Health Sciences, School of Biomedical and Technological Sciences Department of Morphological and Forensic Sciences, Valencia, Venezuela.

The antibody repertoire (Rep-seq) sequencing revolutionized the diversity of antigen B cell receptor studies, allowing deep and quantitative analysis to decipher the role of adaptive immunity in health and disease. Particularly, horse (Equus caballus) polyclonal antibodies have been produced and used since the century XIX to treat and prophylaxis diphtheria, tuberculosis, tetanus, pneumonia, and, more recently, COVID-19. However, our knowledge about the horse B cell receptors repertories is minimal. We present a deep horse antibody heavy chain repertoire (IGH) characterization of non-infected horses using NGS (Next generation sequencing). This study obtained a mean of 248,169 unique IgM clones and 66,141 unique IgG clones from four domestic adult horses. Rarefaction analysis showed sequence coverage was between 52 % and 82 % in IgM and IgG isotypes. We observed that besides horses antibody can use all functional IGHV genes, around 80 % of their antibodies use only three IGHV gene segments, and around 55 % use only one IGHJ gene segment. This limited VJ diversity seems to be compensated by the junctional diversity of these antibodies. We observed that the junctional diversity in horse antibodies is widespread, present in more than 90 % of horse antibodies. Besides this, the length of this region seems to be higher in horse antibodies than in other species. N1 and N2 nucleotides addition range from 0 to 111 nucleotides. In addition, around 45 % of the antibody clones have more than ten nucleotides in both the N1 and N2 junction regions. This diversity mechanism may be one of the most important in providing variability to the equine antibody repertoire. This study provides new insights regarding horse antibody composition, diversity generation, and particularities compared to other species, such as the frequency and length of N nucleotide addition. This study also points out the urgent need to better characterize TdT in horses and other species to better understand antibody repertoire characteristics.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D009711 Nucleotides The monomeric units from which DNA or RNA polymers are constructed. They consist of a purine or pyrimidine base, a pentose sugar, and a phosphate group. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleotide
D011947 Receptors, Antigen, B-Cell IMMUNOGLOBULINS on the surface of B-LYMPHOCYTES. Their MESSENGER RNA contains an EXON with a membrane spanning sequence, producing immunoglobulins in the form of type I transmembrane proteins as opposed to secreted immunoglobulins (ANTIBODIES) which do not contain the membrane spanning segment. Antigen Receptors, B-Cell,B-Cell Antigen Receptor,B-Cell Antigen Receptors,Surface Immunoglobulin,Immunoglobulins, Membrane-Bound,Immunoglobulins, Surface,Membrane Bound Immunoglobulin,Membrane-Bound Immunoglobulins,Receptors, Antigen, B Cell,Surface Immunoglobulins,Antigen Receptor, B-Cell,Antigen Receptors, B Cell,B Cell Antigen Receptor,B Cell Antigen Receptors,Bound Immunoglobulin, Membrane,Immunoglobulin, Membrane Bound,Immunoglobulin, Surface,Immunoglobulins, Membrane Bound,Membrane Bound Immunoglobulins,Receptor, B-Cell Antigen,Receptors, B-Cell Antigen
D006736 Horses Large, hoofed mammals of the family EQUIDAE. Horses are active day and night with most of the day spent seeking and consuming food. Feeding peaks occur in the early morning and late afternoon, and there are several daily periods of rest. Equus caballus,Equus przewalskii,Horse, Domestic,Domestic Horse,Domestic Horses,Horse,Horses, Domestic
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000916 Antibody Diversity The phenomenon of immense variability characteristic of ANTIBODIES. It enables the IMMUNE SYSTEM to react specifically against the essentially unlimited kinds of ANTIGENS it encounters. Antibody diversity is accounted for by three main theories: (1) the Germ Line Theory, which holds that each antibody-producing cell has genes coding for all possible antibody specificities, but expresses only the one stimulated by antigen; (2) the Somatic Mutation Theory, which holds that antibody-producing cells contain only a few genes, which produce antibody diversity by mutation; and (3) the Gene Rearrangement Theory, which holds that antibody diversity is generated by the rearrangement of IMMUNOGLOBULIN VARIABLE REGION gene segments during the differentiation of the ANTIBODY-PRODUCING CELLS. Germ Line Theory,Antibody Diversities,Diversities, Antibody,Diversity, Antibody,Germ Line Theories,Theories, Germ Line,Theory, Germ Line

Related Publications

Carlena Navas, and Taciana Manso, and Fabio Martins, and Lucas Minto, and Rennan Moreira, and João Minozzo, and Bruno Antunes, and André Vale, and Jonathan R McDaniel, and Gregory C Ippolito, and Liza F Felicori
January 2014, PloS one,
Carlena Navas, and Taciana Manso, and Fabio Martins, and Lucas Minto, and Rennan Moreira, and João Minozzo, and Bruno Antunes, and André Vale, and Jonathan R McDaniel, and Gregory C Ippolito, and Liza F Felicori
July 2011, Science translational medicine,
Carlena Navas, and Taciana Manso, and Fabio Martins, and Lucas Minto, and Rennan Moreira, and João Minozzo, and Bruno Antunes, and André Vale, and Jonathan R McDaniel, and Gregory C Ippolito, and Liza F Felicori
October 2013, Molecular immunology,
Carlena Navas, and Taciana Manso, and Fabio Martins, and Lucas Minto, and Rennan Moreira, and João Minozzo, and Bruno Antunes, and André Vale, and Jonathan R McDaniel, and Gregory C Ippolito, and Liza F Felicori
January 2018, Frontiers in immunology,
Carlena Navas, and Taciana Manso, and Fabio Martins, and Lucas Minto, and Rennan Moreira, and João Minozzo, and Bruno Antunes, and André Vale, and Jonathan R McDaniel, and Gregory C Ippolito, and Liza F Felicori
September 1984, Journal of immunology (Baltimore, Md. : 1950),
Carlena Navas, and Taciana Manso, and Fabio Martins, and Lucas Minto, and Rennan Moreira, and João Minozzo, and Bruno Antunes, and André Vale, and Jonathan R McDaniel, and Gregory C Ippolito, and Liza F Felicori
February 2010, Molecular immunology,
Carlena Navas, and Taciana Manso, and Fabio Martins, and Lucas Minto, and Rennan Moreira, and João Minozzo, and Bruno Antunes, and André Vale, and Jonathan R McDaniel, and Gregory C Ippolito, and Liza F Felicori
February 2019, Nature,
Carlena Navas, and Taciana Manso, and Fabio Martins, and Lucas Minto, and Rennan Moreira, and João Minozzo, and Bruno Antunes, and André Vale, and Jonathan R McDaniel, and Gregory C Ippolito, and Liza F Felicori
January 1998, Vaccine,
Carlena Navas, and Taciana Manso, and Fabio Martins, and Lucas Minto, and Rennan Moreira, and João Minozzo, and Bruno Antunes, and André Vale, and Jonathan R McDaniel, and Gregory C Ippolito, and Liza F Felicori
October 1997, Journal of immunology (Baltimore, Md. : 1950),
Carlena Navas, and Taciana Manso, and Fabio Martins, and Lucas Minto, and Rennan Moreira, and João Minozzo, and Bruno Antunes, and André Vale, and Jonathan R McDaniel, and Gregory C Ippolito, and Liza F Felicori
April 1998, European journal of immunology,
Copied contents to your clipboard!